Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and MetoprololCompleted
NCT02940379Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States
Surveillance Program to Determine Product Specific Rates of Invasive Hib DiseaseCompleted
NCT00855855N/AUpdated Apr 25, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Haemophilus Infections · Diphtheria · Tetanus · Polio
United States
Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompleted
NCT03359837Phase 4Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
China
A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy SubjectsCompleted
NCT03174548Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Diabetes Mellitus
United Kingdom
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)Completed
NCT03529123Phase 3Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
India
Effect of Venglustat in Patients With Renal ImpairmentCompleted
NCT03687554Phase 1Updated Apr 25, 2022
Sponsor: Genzyme, a Sanofi Company
Healthy Volunteers · Polycystic Kidney, Autosomal Dominant
United States
Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug NaiveCompleted
NCT03794336Phase 4Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
China
A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinCompleted
NCT02967211Phase 4Updated Apr 25, 2022
Sponsor: Sanofi
Diabetes Mellitus, Type 2
Brazil, Finland, France, Greece, Ireland +5 more
Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic TherapyCompleted
NCT02855684Phase 3Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
China, South Korea, Taiwan
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent PatientsCompleted
NCT03463135Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Food Allergy
United States
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)Completed
NCT02803918Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States, Mauritius, Mexico, South Africa, Spain +1 more
Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute LeukemiaCompleted
NCT04349306Phase 4Updated Apr 25, 2022
Sponsor: Sanofi
Lymphoma
China
Postmarketing Surveillance Study for IMOJEV® in Republic of KoreaCompleted
NCT02933710N/AUpdated Apr 25, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Japanese Encephalitis
South Korea
A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)Completed
NCT03317015Phase 3Updated Apr 25, 2022
Sponsor: Sanofi
Rhinitis Allergic
Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus PatientsCompleted
NCT03436498Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States
Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian FederationCompleted
NCT02699840N/AUpdated Apr 25, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Meningitis · Meningococcal Meningitis · Meningococcal Infections
Russia
DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese InfantsCompleted
NCT02274285Phase 3Updated Apr 25, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Tetanus · Diphtheria · Pertussis · Poliomyelitis
Japan
A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCompleted
NCT02910518Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type1 Diabetes Mellitus
Germany
Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate HypertensionCompleted
NCT03462069Phase 2Updated Apr 25, 2022
Sponsor: Sanofi
Diabetes Mellitus
Germany
A Study of RG-012 in Subjects With Alport SyndromeCompleted
NCT03373786Phase 1Updated Apr 25, 2022
Sponsor: Genzyme, a Sanofi Company
Alport Syndrome
United States
A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes MellitusCompleted
NCT03202875Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 1 Diabetes
Germany
A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in CanadaCompleted
NCT03958799Phase 1Updated Apr 25, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Tetanus Immunisation (Healthy Volunteers) · Diphtheria Immunisation (Healthy Volunteers) · Pertussis Immunisation (Healthy Volunteers)
Canada
Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One YearCompleted
NCT03700242Phase 3Updated Apr 25, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Healthy Volunteers (Rabies Immunization)
Philippines
Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of DiabetesCompleted
NCT03312478Phase 4Updated Apr 25, 2022
Sponsor: Sanofi
Type 1 Diabetes
Pakistan
Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female SubjectsCompleted
NCT03802487Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus · Healthy Subjects
United Kingdom

Previous page Next page